Trial Profile

An Observational, Safety and Efficacy Study in Subjects Using Levemir (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin detemir (Primary)
Indications Type 2 diabetes mellitus
Focus Pharmacodynamics
Acronyms DIABESITY
Sponsors Novo Nordisk

Most Recent Events

16 Oct 2009 Actual patient number changed from 9764 to 9868 as reported by ClinicalTrials.gov.
16 Mar 2009 Actual patient number (9764) added as reported by ClinicalTrials.gov.
16 Mar 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com